ZACHARY SUTTON: Open Payments
NPI 1508167362 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 39 payments from 19 companies in 2025. Trend: 2023 $123 · 2024 $0 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $177 |
| Travere Therapeutics, Inc. | 3 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Novo Nordisk Inc | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 3 | $122 |
| Calliditas Therapeutics US Inc. | 4 | $121 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Madrigal Pharmaceuticals | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Aurinia Pharma U.S., Inc. | 2 | $43 |
Products named: Fabhalta, Ozempic, TARPEYO, Auvelity, REZDIFFRA, EVENITY, Filspari, BREZTRI.
Industry payments across SC — which companies pay providers there.
